In melanoma, FTO promoted the expression of PDCD1, which expresses the PD-1 protein, as well as CXCR4 and SOX10, promoting melanoma tumorigenesis and resistance to immunotherapy [43]. This evidence concerns the gene PDCD1 and melanoma.